23 January 2025
Revolution Beauty Group plc
("Revolution Beauty", the "Group", or the "Company")
FY25 Trading Update
Revolution Beauty Group, the multi-channel mass beauty brand, is today providing an update on trading for the year ending 28 February 2025 ("FY25").
FY25 is a transformational year for Revolution Beauty, during which it has discontinued over 6,000 unproductive SKUs - some 75% of its original portfolio - to create a scalable and profitable foundation for future growth. The Company continues to transition its global retailers onto this core set of products.
Revolution Beauty also continues to make encouraging progress expanding its relationships with existing and new retailers. However, certain retailer launches that were expected in Q4 25 will now take place in H1 26. The scale of these opportunities remains the same, and the launches into Walmart in the US and DM in Germany remain on track for February 2025.
In addition to this phasing impact, the Company experienced some sales softness in December 2024 in its digital channels and an element of de-stocking from USA retailers. As a result, the Company now expects net sales for FY25 to decline c.25% and high single digit millions underlying adjusted EBITDA supported by the continued positive delivery of our operational and cost savings programmes. The one-off stock provision for the non-strategic discontinued stock announced in the interim results remains unchanged. We continue to be in compliance with our banking covenants with sufficient liquidity headroom. Our cash balances were £6m at the end of December 2024 and net debt was £26m including a fully drawn RCF of £32m.
The Company's core SKUs continue to grow, including through channels such as Amazon, which are performing well in both the USA and Europe.
Looking ahead, Revolution Beauty is confident in a return to overall growth in FY26, as new strategic growth initiatives such as the launch of the new SKIN brand, the relaunch of our value brand RELOVE, and as the core SKU growth accelerates globally. This will be underpinned by significant margin improvements in the medium term.
The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018.
For further information please contact:
Investor Relations
Lauren Brindley, CEO
Neil Catto, CFO
Investor.Relations@revolutionbeautyplc.com
Panmure Liberum Limited (Nomad and Joint Broker): Edward Thomas / Dru Danford / John More
Tel: +44 (0) 203 100 2222
Zeus (Joint Broker): Benjamin Robertson / Nick Cowles / Jordan Warburton
Tel: +44 (0) 161 831 1512
Media enquiries
Headland Consultancy: Matt Denham / Antonia Pollock
Tel: +44 (0)20 3805 4822
Revolutionbeauty@headlandconsultancy.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.